LeMaitre Vascular (NASDAQ:LMAT) Shares Gap Down – Time to Sell?

LeMaitre Vascular, Inc. (NASDAQ:LMAT) gapped down prior to trading on Friday . The stock had previously closed at $99.91, but opened at $90.00. LeMaitre Vascular shares last traded at $90.43, with a volume of 50,253 shares.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on LMAT shares. Lake Street Capital upped their target price on shares of LeMaitre Vascular from $105.00 to $110.00 and gave the stock a “buy” rating in a research note on Friday. StockNews.com downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research note on Friday, December 13th. Wells Fargo & Company started coverage on shares of LeMaitre Vascular in a research note on Thursday, February 13th. They issued an “equal weight” rating and a $95.00 target price on the stock. Barrington Research downgraded shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research note on Friday. Finally, Oppenheimer downgraded shares of LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research note on Friday. Five equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $95.25.

LeMaitre Vascular Price Performance

The company has a market cap of $2.07 billion, a P/E ratio of 50.19, a P/E/G ratio of 2.22 and a beta of 0.96. The stock’s 50-day moving average is $96.89 and its two-hundred day moving average is $94.73.

LeMaitre Vascular (NASDAQ:LMAT) last released its quarterly earnings results on Thursday, February 27th. The medical instruments supplier reported $0.49 earnings per share for the quarter, hitting the consensus estimate of $0.49. LeMaitre Vascular had a net margin of 19.40% and a return on equity of 13.15%. The business had revenue of $55.81 million for the quarter, compared to the consensus estimate of $55.99 million. On average, analysts predict that LeMaitre Vascular, Inc. will post 1.94 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the business. New York State Teachers Retirement System raised its position in LeMaitre Vascular by 1.2% in the fourth quarter. New York State Teachers Retirement System now owns 8,189 shares of the medical instruments supplier’s stock worth $755,000 after acquiring an additional 100 shares during the period. Flputnam Investment Management Co. raised its position in LeMaitre Vascular by 3.6% in the fourth quarter. Flputnam Investment Management Co. now owns 2,923 shares of the medical instruments supplier’s stock worth $269,000 after acquiring an additional 102 shares during the period. Norden Group LLC raised its position in LeMaitre Vascular by 4.5% in the fourth quarter. Norden Group LLC now owns 2,371 shares of the medical instruments supplier’s stock worth $218,000 after acquiring an additional 103 shares during the period. Blue Barn Wealth LLC raised its position in LeMaitre Vascular by 4.4% in the fourth quarter. Blue Barn Wealth LLC now owns 2,485 shares of the medical instruments supplier’s stock worth $229,000 after acquiring an additional 104 shares during the period. Finally, Shaker Investments LLC OH raised its position in LeMaitre Vascular by 0.8% in the fourth quarter. Shaker Investments LLC OH now owns 13,948 shares of the medical instruments supplier’s stock worth $1,285,000 after acquiring an additional 112 shares during the period. 84.64% of the stock is currently owned by institutional investors.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.